| Name | napsin A aspartic peptidase |
| Description | This gene encodes a member of the peptidase A1 family of aspartic proteases. The encoded preproprotein is proteolytically processed to generate an activation peptide and the mature protease. The activation peptides of aspartic proteinases function as inhibitors of the protease active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The encoded protease may play a role in the proteolytic processing of pulmonary surfactant protein B in the lung and may function in protein catabolism in the renal proximal tubules. This gene has been described as a marker for lung adenocarcinoma and renal cell carcinoma. [provided by RefSeq, Feb 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNapsin A is an aspartic proteinase predominantly expressed in type II pneumocytes where it performs a key role in the proteolytic processing of pro–surfactant protein B, a function essential for the generation of active pulmonary surfactant. Its expression in lung tissue and its high sensitivity as an immunohistochemical marker have established its utility in the diagnosis and subclassification of lung adenocarcinomas, particularly when used in combination with thyroid transcription factor‐1 to improve both sensitivity and specificity. This critical role in pulmonary homeostasis and cancer diagnostics was first highlighted in studies focusing on non‐small cell carcinomas, where napsin A demonstrated superior performance in identifying adenocarcinoma compared to traditional markers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its pivotal role in pulmonary biology, napsin A expression extends to several non–lung neoplasms where it assists in diagnostic differentiation. It is expressed in specific subsets of renal cell carcinomas (especially papillary types), ovarian clear cell carcinomas, endometrial clear cell tumors, and certain mesothelial as well as gynecologic lesions. The distinct immunoprofile of napsin A, particularly when evaluated as part of a panel with markers such as TTF‐1, PAX8, p63, CK5/6, and hepatocyte nuclear factor‑1β, provides critical support for distinguishing primary lung adenocarcinomas from metastatic lesions and for accurately subtyping tumors with similar histomorphology. This expanded expression pattern underlines its diagnostic value across a broad spectrum of carcinomas."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent mechanistic studies have further expanded our understanding of napsin A by implicating it in tumor biology and response to therapy. Not only does its enzymatic activity contribute to the maturation of surfactant proteins in the lung, but experimental evidence also suggests that napsin A may exert tumor‐suppressive effects—including inhibition of anchorage-independent growth and attenuation of epithelial–mesenchymal transition, which in turn can enhance sensitivity to targeted therapies such as EGFR tyrosine kinase inhibitors. Moreover, alterations in its expression have been correlated with clinicopathologic parameters and patient outcomes, underscoring the biomarker’s prognostic significance. These insights, derived from a combination of molecular, immunohistochemical, and functional studies, highlight the multifaceted clinical importance of napsin A both as a diagnostic marker and as a potential modulator of tumor behavior."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "47"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Justin A Bishop, Rajni Sharma, Peter B Illei "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2009.06.014"}], "href": "https://doi.org/10.1016/j.humpath.2009.06.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19740516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19740516"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sanjay Mukhopadhyay, Anna-Luise A Katzenstein "}, {"type": "b", "children": [{"type": "t", "text": "Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0b013e3182036d05"}], "href": "https://doi.org/10.1097/PAS.0b013e3182036d05"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21164283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21164283"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Bradley M Turner, Philip T Cagle, Irma M Sainz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Pathol Lab Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5858/arpa.2011-0320-OA"}], "href": "https://doi.org/10.5858/arpa.2011-0320-OA"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22288963"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22288963"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "T Ueno, S Linder, G Elmberger "}, {"type": "b", "children": [{"type": "t", "text": "Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6600879"}], "href": "https://doi.org/10.1038/sj.bjc.6600879"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12698189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12698189"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jiqing Ye, Jennifer J Findeis-Hosey, Qi Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0b013e318205b059"}], "href": "https://doi.org/10.1097/PAI.0b013e318205b059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21464700"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21464700"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Frank Brasch, Matthias Ochs, Thilo Kahne, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M306844200"}], "href": "https://doi.org/10.1074/jbc.M306844200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "13129928"}], "href": "https://pubmed.ncbi.nlm.nih.gov/13129928"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lisa M Stoll, Michael W Johnson, Edward Gabrielson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cytopathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncy.20108"}], "href": "https://doi.org/10.1002/cncy.20108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20830690"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20830690"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Oluwole Fadare, Mohamed M Desouki, Katja Gwin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0000000000000085"}], "href": "https://doi.org/10.1097/PAS.0000000000000085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24145649"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24145649"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yoriko Yamashita, Tetsuro Nagasaka, Aya Naiki-Ito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is a specific marker for ovarian clear cell adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2014.61"}], "href": "https://doi.org/10.1038/modpathol.2014.61"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24721826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24721826"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Masami Iwamoto, Yukio Nakatani, Kazunori Fugo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2015.03.008"}], "href": "https://doi.org/10.1016/j.humpath.2015.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25971546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25971546"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Oluwole Fadare, Chengquan Zhao, Dineo Khabele, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAT.0000000000000223"}], "href": "https://doi.org/10.1097/PAT.0000000000000223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25551297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25551297"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "J Ye, O Hameed, J J Findeis-Hosey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotech Histochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/10520295.2011.591838"}], "href": "https://doi.org/10.3109/10520295.2011.591838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21838611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21838611"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Nelson G Ordóñez "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A expression in lung and kidney neoplasia: a review and update."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Anat Pathol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAP.0b013e31823e472e"}], "href": "https://doi.org/10.1097/PAP.0b013e31823e472e"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22156835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22156835"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Maryam Kadivar, Behnaz Boozari "}, {"type": "b", "children": [{"type": "t", "text": "Applications and limitations of immunohistochemical expression of \"Napsin-A\" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0b013e3182612643"}], "href": "https://doi.org/10.1097/PAI.0b013e3182612643"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22914608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22914608"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Patricia L Kandalaft, Allen M Gown, Christina Isacson "}, {"type": "b", "children": [{"type": "t", "text": "The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1309/AJCP8WO2EOIAHSOF"}], "href": "https://doi.org/10.1309/AJCP8WO2EOIAHSOF"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25389337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25389337"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Simone B S P Terra, Marie Christine Aubry, Eunhee S Yi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2013.09.005"}], "href": "https://doi.org/10.1016/j.humpath.2013.09.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24331839"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24331839"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ingiridur Skirnisdottir, Kathrine Bjersand, Helena Akerud, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A as a marker of clear cell ovarian carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-13-524"}], "href": "https://doi.org/10.1186/1471-2407-13-524"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24191930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24191930"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jeffrey Wu, Peiguo G Chu, Zhong Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1309/AJCP62WJUAMSZCOM"}], "href": "https://doi.org/10.1309/AJCP62WJUAMSZCOM"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23355200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23355200"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jin Gu Lee, Sewha Kim, Hyo Sup Shim "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lung Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lungcan.2012.02.013"}], "href": "https://doi.org/10.1016/j.lungcan.2012.02.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22418245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22418245"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Rebecca D Chernock, Samir K El-Mofty, Nils Becker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0b013e318283b7b2"}], "href": "https://doi.org/10.1097/PAS.0b013e318283b7b2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23681073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23681073"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Lena Tran, Johanna S M Mattsson, Björn Nodin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000235"}], "href": "https://doi.org/10.1097/PAI.0000000000000235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26447895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26447895"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Nelson G Ordóñez "}, {"type": "b", "children": [{"type": "t", "text": "Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2013.34"}], "href": "https://doi.org/10.1038/modpathol.2013.34"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23503645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23503645"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Takayuki Ueno, Göran Elmberger, Timothy E Weaver, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/labinvest.3700718"}], "href": "https://doi.org/10.1038/labinvest.3700718"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18195689"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18195689"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Nelson G Ordóñez "}, {"type": "b", "children": [{"type": "t", "text": "A word of caution regarding napsin A expression in squamous cell carcinomas of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0b013e31823b13e2"}], "href": "https://doi.org/10.1097/PAS.0b013e31823b13e2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22198009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22198009"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yetkin Agackiran, Aysenaz Ozcan, Nalan Akyurek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0b013e318245c730"}], "href": "https://doi.org/10.1097/PAI.0b013e318245c730"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22495379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22495379"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Emiko Aikawa, Akihiko Kawahara, Satoshi Hattori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cytopathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncy.20162"}], "href": "https://doi.org/10.1002/cncy.20162"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21717589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21717589"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yunfan Ma, Mengying Fan, Liang Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3478-z"}], "href": "https://doi.org/10.1007/s13277-015-3478-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25982999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25982999"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Qing Li, Xin Zeng, Xue Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26339401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26339401"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Bing Zhu, Stephen M Rohan, Xiaoqi Lin "}, {"type": "b", "children": [{"type": "t", "text": "Immunoexpression of napsin A in renal neoplasms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diagn Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13000-015-0242-z"}], "href": "https://doi.org/10.1186/s13000-015-0242-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25889632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25889632"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Rajni Sharma, Yuting Wang, Li Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2016.02.027"}], "href": "https://doi.org/10.1016/j.humpath.2016.02.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27045515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27045515"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Morgan L Cowan, Qing K Li, Peter B Illei "}, {"type": "b", "children": [{"type": "t", "text": "CDX-2 Expression in Primary Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000250"}], "href": "https://doi.org/10.1097/PAI.0000000000000250"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26469326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26469326"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jaudah A Al-Maghrabi, Nadeem S Butt, Nisrin Anfinan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000350"}], "href": "https://doi.org/10.1097/PAI.0000000000000350"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26945446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26945446"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Karen L Talia, Richard Wing-Cheuk Wong, W Glenn McCluggage "}, {"type": "b", "children": [{"type": "t", "text": "Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gynecol Pathol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PGP.0000000000000529"}], "href": "https://doi.org/10.1097/PGP.0000000000000529"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29901522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29901522"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Kanwaijit S Aulakh, Cary D Chisholm, Daniel A Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Pathol Lab Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5858/arpa.2012-0305-OA"}], "href": "https://doi.org/10.5858/arpa.2012-0305-OA"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23899066"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23899066"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Jennifer Pors, Sheila Segura, Angela Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000801"}], "href": "https://doi.org/10.1097/PAI.0000000000000801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31361605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31361605"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Michiya Nishino, Mai P Hoang, Patricia Della Pelle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cytopathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncy.21707"}], "href": "https://doi.org/10.1002/cncy.21707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27412420"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27412420"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Lindsay A Schmidt, Jeffrey L Myers, Jonathan B McHugh "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is differentially expressed in sclerosing hemangiomas of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Pathol Lab Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5858/arpa.2011-0486-OA"}], "href": "https://doi.org/10.5858/arpa.2011-0486-OA"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23194051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23194051"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Nima Sharifai, Brooj Abro, Jie-Fu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2020.05.007"}], "href": "https://doi.org/10.1016/j.humpath.2020.05.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32561332"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32561332"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Matthew Cook, Frank Bühling, Siegfried Ansorge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pronapsin A and B gene expression in normal and malignant human lung and mononuclear blood cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0167-4781(02)00400-1"}], "href": "https://doi.org/10.1016/s0167-4781(02"}, {"type": "t", "text": "00400-1) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12151090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12151090"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Taisia Vitkovski, Shweta Chaudhary, Cristina Sison, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Surg Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1066896916629781"}], "href": "https://doi.org/10.1177/1066896916629781"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26842346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26842346"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Deepali Jain, Saumya R Mallick, Varsha Singh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000289"}], "href": "https://doi.org/10.1097/PAI.0000000000000289"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26808134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26808134"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Linshui Zhou, Xin Lv, Junchao Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is negatively associated with EMT‑mediated EGFR‑TKI resistance in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.9075"}], "href": "https://doi.org/10.3892/mmr.2018.9075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29845258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29845258"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Toshiaki Kawai, Susumu Tominaga, Sadayuki Hiroi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Cytol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000442659"}], "href": "https://doi.org/10.1159/000442659"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26696549"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26696549"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Kazuhisa Nishishita, Eiko Sakai, Kuniaki Okamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural and phylogenetic comparison of napsin genes: the duplication, loss of function and human-specific pseudogenization of napsin B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2013.01.013"}], "href": "https://doi.org/10.1016/j.gene.2013.01.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23333608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23333608"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Giovanna Giordano, Nicoletta Campanini, Elena Varotti "}, {"type": "b", "children": [{"type": "t", "text": "Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-020-02809-5"}], "href": "https://doi.org/10.1007/s00428-020-02809-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32270298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32270298"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "Moon-Young Kim, Heounjeong Go, Jaemoon Koh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histopathology (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/his.12383"}], "href": "https://doi.org/10.1111/his.12383"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24479710"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24479710"}]}, {"type": "r", "ref": 47, "children": [{"type": "t", "text": "M Woischnik, A Bauer, R Aboutaam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Respir J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1183/09031936.00081207"}], "href": "https://doi.org/10.1183/09031936.00081207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18216060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18216060"}]}]}]}
|
| Synonyms | KAP, Kdap, NAPA |
| Proteins | NAPSA_HUMAN |
| NCBI Gene ID | 9476 |
| API | |
| Download Associations | |
| Predicted Functions |
 |
| Co-expressed Genes |
|
| Expression in Tissues and Cell Lines |
|
NAPSA has 6,369 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 103 datasets.
Click the + buttons to view associations for NAPSA from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by NAPSA gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAPSA gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAPSA gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NAPSA gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAPSA gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAPSA gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NAPSA gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAPSA gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NAPSA gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NAPSA gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NAPSA gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NAPSA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NAPSA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NAPSA gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NAPSA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NAPSA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NAPSA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NAPSA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAPSA gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NAPSA gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NAPSA gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NAPSA gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NAPSA gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NAPSA gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NAPSA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NAPSA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NAPSA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NAPSA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NAPSA gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NAPSA gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NAPSA gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NAPSA from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NAPSA gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NAPSA from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NAPSA gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NAPSA gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NAPSA gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAPSA gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NAPSA gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NAPSA gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NAPSA gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NAPSA gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NAPSA gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NAPSA protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NAPSA protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NAPSA protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NAPSA gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NAPSA gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NAPSA gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NAPSA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NAPSA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAPSA gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NAPSA gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NAPSA gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NAPSA gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NAPSA gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NAPSA gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NAPSA protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAPSA gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NAPSA from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NAPSA gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NAPSA protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NAPSA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NAPSA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NAPSA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving NAPSA protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAPSA gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NAPSA gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NAPSA gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NAPSA gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NAPSA protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NAPSA gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NAPSA gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NAPSA gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NAPSA gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing NAPSA protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NAPSA from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NAPSA gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NAPSA gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NAPSA protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NAPSA protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving NAPSA protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAPSA gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAPSA gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAPSA gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NAPSA gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAPSA gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NAPSA gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NAPSA gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NAPSA gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NAPSA gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with NAPSA protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NAPSA gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NAPSA gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NAPSA gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NAPSA gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NAPSA gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NAPSA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NAPSA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NAPSA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NAPSA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NAPSA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NAPSA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
